Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop

Journal article

β-cell replacement therapy, available currently as pancreas or islet transplantation, has developed without a clear definition of graft functional and clinical outcomes. The International Pancreas and Islet Transplant Association and European Pancreas and Islet Transplantation Association held a workshop to develop consensus for an International Pancreas and Islet Transplant Association and European Pancreas and Islet Transplant Association Statement on the definition of function and failure ...

Expand abstract

Authors: Rickels, MR; Stock, PG; De Koning, EJP; Piemonti, L; Pratschke, J

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: Lippincott, Williams & Wilkins
• Journal: Transplantation
• Volume: 102
• Issue: 9
• Pages: 1479-1486
• Publication date: 2018-09-01
• Acceptance date: 2018-09-01
• DOI: 10.1097/TP.0000000000002158
• ISSN: 1534-6080 and 0041-1337
• Pmid: 29528967
• Language: English
• Keywords: Treatment Outcome; Consensus Development Conference; Humans; C-Peptide; Research Support, N.I.H., Extramural; Hypoglycemic Agents; Review; Research Support, Non-U.S. Gov't; Consensus; Risk Factors; research-article; Diabetes Mellitus; Practice Guideline; Glycated Hemoglobin A; Journal Article; Blood Glucose; Biomarkers; Islets of Langerhans Transplantation; Hypoglycemia; Insulin-Secreting Cells